National Kidney Foundation's Primer on Kidney Diseases
-
- Taschenbuch ausgewählt
- eBook
-
Sprache:Englisch
-
Auflage:9th edition
- 8th edition 116,99 €
- 9th edition 88,99 € ausgewählt
88,99 €
inkl. gesetzl. MwSt.,
Beschreibung
Produktdetails
Einband
Taschenbuch
Erscheinungsdatum
25.12.2026
Herausgeber
Scott F. Gilbert + weitereVerlag
ElsevierSeitenzahl
688
Maße (L/B)
27,6/21,6 cm
Gewicht
449 g
Auflage
9th edition
Sprache
Englisch
ISBN
978-0-443-26193-0
Covering every relevant topic in this fast-changing field, National Kidney Foundation's Primer on Kidney Diseases, 9th Edition, remains your #1 source of practical, authoritative information in nephrology. Using a clear, concise, and accessible format, this bestselling guide provides well organized, highly readable guidance for residency, fellowship, clinical practice, and board review. The fully revised Primer brings you up to date with all that’s new in the field, including ongoing clinical research and changing treatment protocols. Offering authoritative coverage of the full breadth of nephrology from world leaders in their field, this joint publication of Elsevier and the National Kidney Foundation is both an essential learning tool for trainees and an easy-to-use, reliable reference for practicing clinicians at the point of care.
- Provides clear, comprehensive coverage of every aspect of nephrology- from foundational science and clinical evaluation to glomerular disease, systemic disease, AKI, CKD, dialysis, transplantation, pediatrics, pregnancy, and hypertension
- Presents complex material in a clear, easy-to-understand manner that is both accessible to residents and fellows and comprehensive enough for practicing nephrologists
- Contains a new chapter on Critical Care Nephrology that equips clinicians with a practical, phenotype¿driven approach to diagnosing and managing AKI in the ICU
- Covers major advances in treating glomerular diseases, including updated KDIGO guidelines and the rapid growth of precision therapies such as C3 inhibitors, BTK inhibitors, and podocyte¿targeted agents
- Includes new and expanded coverage of SGLT2 inhibitors, nonsteroidal MRAs, and GLP¿1 receptor agonists for kidney and cardiovascular protection in diabetic and non¿diabetic CKD
- An eBook version is included with purchase. The eBook allows you to access all of the text, figures, and references, with the ability to search, make notes and highlights, and have content read aloud. Additional digital ancillary content may publish after the publication date
Noch keine Bewertungen vorhanden
Verfassen Sie die erste Bewertung zu diesem Artikel
Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.
Kurze Frage zu unserer Seite
Vielen Dank für Ihr Feedback
Wir nutzen Ihr Feedback, um unsere Produktseiten zu verbessern. Bitte haben Sie Verständnis, dass wir Ihnen keine Rückmeldung geben können. Falls Sie Kontakt mit uns aufnehmen möchten, können Sie sich aber gerne an unseren Kund*innenservice wenden.
zum Kundenservice